rts logo

Ginkgo Bioworks Holdings Inc (DNA) Looks Ready for Growth Despite -81.74% Change This Year

Ginkgo Bioworks Holdings Inc (NYSE: DNA) is -81.74% lower on its value in year-to-date trading and has touched a low of $0.26 and a high of $2.55 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The DNA stock was last observed hovering at around $0.34 in the last trading session, with the day’s loss setting it -0.03%.

Currently trading at $0.31, the stock is -22.62% and -49.85% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 34.93 million and changing -9.37% at the moment leaves the stock -74.09% off its SMA200. DNA registered -82.56% loss for a year compared to 6-month loss of -79.83%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a -43.89% gain in the last 1 month and extending the period to 3 months gives it a -72.20%, and is -4.52% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.19% over the week and 12.53% over the month.

Ginkgo Bioworks Holdings Inc (DNA) has around 1218 employees, a market worth around $651.78M and $208.70M in sales. Profit margin for the company is -409.12%. Distance from 52-week low is 16.81% and -87.87% from its 52-week high. The company has generated returns on investments over the last 12 months (-69.88%).

with sales reaching $43.14M over the same period.The EPS is expected to grow by 37.28% this year, but quarterly earnings will post -28.60% year-over-year. Quarterly sales are estimated to shrink -46.50% in year-over-year returns.

Ginkgo Bioworks Holdings Inc (DNA) Top Institutional Holders

The shares outstanding are 1.53B, and float is at 1.42B with Short Float at 16.78%.

Ginkgo Bioworks Holdings Inc (DNA) Insider Activity

The most recent transaction is an insider sale by Dmytruk Mark E.,the company’s. SEC filings show that Dmytruk Mark E. sold 49,162 shares of the company’s common stock on Jul 02 ’24 at a price of $0.33 per share for a total of $16027.0. Following the sale, the insider now owns 1.04 million shares.

Ginkgo Bioworks Holdings Inc disclosed in a document filed with the SEC on Jul 02 ’24 that Coen Steven P. () sold a total of 13,520 shares of the company’s common stock. The trade occurred on Jul 02 ’24 and was made at $0.33 per share for $4408.0. Following the transaction, the insider now directly holds 0.2 million shares of the DNA stock.

Still, SEC filings show that on Jun 03 ’24, Dmytruk Mark E. () disposed off 48,866 shares at an average price of $0.55 for $26827.0. The insider now directly holds 984,662 shares of Ginkgo Bioworks Holdings Inc (DNA).

Related Posts